Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02808494 · ClinicalTrials.gov registry record
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
A clinical trial, sponsored by Illumina.
- Completed
- Registry status
- 242
- Enrollment target
NCT02808494 is a clinical trial that has completed, run by Illumina. The registered enrollment target is 242 participants.
The verdict
NCT02808494 has completed, sponsored by Illumina.
- COMPLETED
- Registry status
- 242 participants
- Enrollment target
Study Summary
Sample Collection Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-11-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02808494
The ClinicalTrials.gov registry entry for NCT02808494 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 242 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Illumina, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02808494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02808494 about?
NCT02808494 is a clinical study titled "Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers". Sample Collection Study
What is the current status of trial NCT02808494?
This trial is currently completed. The enrollment target is 242 participants. The study started on 2016-03. Estimated completion is 2017-11-20.
Who is sponsoring clinical trial NCT02808494?
This trial is sponsored by Illumina, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.